{"id":51881,"date":"2026-02-10T15:17:14","date_gmt":"2026-02-10T15:17:14","guid":{"rendered":"https:\/\/ciaoup.it\/?p=51881"},"modified":"2026-02-10T15:17:14","modified_gmt":"2026-02-10T15:17:14","slug":"asymbio-establishes-integrated-technology-platforms-spanning-the-full-biopharmaceutical-development-lifecycle","status":"publish","type":"post","link":"https:\/\/ciaoup.it\/?p=51881","title":{"rendered":"AsymBio Establishes Integrated Technology Platforms Spanning the Full Biopharmaceutical Development Lifecycle"},"content":{"rendered":"

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE<\/p>\n

SHANGHAI, Feb. 10, 2026 \/PRNewswire\/ — AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ \/ 6821.HK), announced that it has established integrated technology platforms spanning the full biopharmaceutical development lifecycle. Through its end-to-end service capabilities, the company provides streamlined, integrated workflows from early development to commercial manufacturing.\u00a0<\/p>\n

AsymBio is a technology-driven biopharmaceutical CDMO focused on accelerating innovation through integrated development and manufacturing services for clients. Key platforms include:\u00a0<\/p>\n

AsymBio will continue to invest in R&D and technology development through advanced technology platforms and data-enabled manufacturing processes. By integrating advanced scientific approaches with large-scale manufacturing experience, AsymBio works to help global clients address complex development challenges, improve manufacturing efficiency and product quality, and support reliable commercialization of innovative therapies.\u00a0<\/p>\n

About AsymBio\u00a0<\/p>\n

AsymBio focuses exclusively on biopharmaceutical CDMO services. The company delivers one-stop CDMO services from early-stage development to clinical, toxicology, and commercial-scale manufacturing. AsymBio is also expanding beyond ADCs into NDCs while maintaining comprehensive capabilities for antibody therapeutics and recombinant proteins.\u00a0<\/p>\n

For more information, visit www.asymbio.com or follow us on LinkedIn.Business inquiries: MKT@asymchem.com.cn
\n\u00a0<\/p>\n

Logo – https:\/\/mma.prnewswire.com\/media\/2888481\/5775993\/AsymBio_Logo.jpg
\n\u00a0<\/p>\n

View original content:https:\/\/www.prnewswire.co.uk\/news-releases\/asymbio-establishes-integrated-technology-platforms-spanning-the-full-biopharmaceutical-development-lifecycle-302682462.html
\n\u00a0<\/p>\n

Copyright 2026 PR Newswire. All Rights Reserved.\u00a0<\/p>\n

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE: Immediapress è un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. L’Adnkronos e Immediapress non sono responsabili per i contenuti dei comunicati trasmessi<\/p>\n

—<\/p>\n

immediapress\/pr-newswire<\/p><\/p>\n

\n\t\t<\/a>\n\t\t<\/div>","protected":false},"excerpt":{"rendered":"

COMUNICATO STAMPA – CONTENUTO PROMOZIONALE SHANGHAI, Feb. 10, 2026 \/PRNewswire\/ — AsymBio, a subsidiary of…<\/p>\n","protected":false},"author":3,"featured_media":51882,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[23],"class_list":["post-51881","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-comunicati","tag-immediapress"],"_links":{"self":[{"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/posts\/51881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=51881"}],"version-history":[{"count":1,"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/posts\/51881\/revisions"}],"predecessor-version":[{"id":51893,"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/posts\/51881\/revisions\/51893"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=\/wp\/v2\/media\/51882"}],"wp:attachment":[{"href":"https:\/\/ciaoup.it\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=51881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=51881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ciaoup.it\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=51881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}